visiongain
Print this page . Send to a friend . Bookmark this page
Login/Register  BasketBasket Checkout
  • visiongain
    • defence defence
    • energy energy
    • paper paper
    • packaging packaging
    • utility utility
    • telecoms & IT telecoms & IT
    • metals metals
    • aviation aviation
    • plastics plastics
    • pharma pharma
    • renewable energy renewable energy
    • your guide to your industry your guide to your industry

welcome to visiongain

Visiongain is the place you need to know about to meet your most important business information needs. This portal will offer you accurate, up-to-date news and analysis on the key areas of your business sector, along with the opportunity to network with industry peers and market leaders. You can stay ahead with our:

Reports: visiongain reports cover the most important areas of your business sector. Researched by our team experts, they will provide you with accurate information and insightful analysis.

Conferences: visiongain conferences provide you with the opportunity to hear market leaders speak on the most important issues concerning your business, along with excellent networking opportunities.

Newsletters: visiongain newsletters give you access to the most important daily news affecting your industry, keeping you informed through reliable sources.

latest reports

visiongain RSS Feed

  • The Unmanned Aerial Vehicles (UAV) Market 2012-2022: Technologies for ISR & Counter Insurgency

    Unmanned aerial vehicles (UAVs) are becoming increasingly important for militaries worldwide. UAVs are expected to perform key roles in current and future forces, thus providing robust demand over the next decade. UAVs are taking on a range of battlefield tasks, and have proven critical to intelligence gathering, targeting, and situational awareness; while armed UAVs are being used in attack missions where a persistent presence is required, or where manned aircraft operations are deemed unsuitable. There is also an emerging market for civil or non-military UAVs, that has received significant impetus from the US plan to integrate UAVs into national airspace.

  • The Gas Utilities Infrastructure Market 2012-2022

    A combination of ageing infrastructure, rising use of natural gas as an energy source, a need to improve distribution efficiency and energy security, and reduce greenhouse gas emissions are all driving capital expenditure growth in the gas utilities infrastructure market. Over the forecast period many regions and countries will experience strong growth in the gas utilities infrastructures market as new gas infrastructure is built to meet rising demand. More established gas markets will need to upgrade ageing and insufficient distribution infrastructure. Visiongain has determined that capital expenditure in the global gas utility infrastructure market in 2012 will reach $36.13bn

  • The UAV Flight Training & Simulation Market 2012-2022

    The proliferation of UAVs, and their utility on the modern battlefield, will see demand for the vital services they offer continue into the next decade. This demand will be accompanied by a requirement for more skilled UAV pilots and sensor operators, and as UAV operator training becomes more formalised, governments will be looking to invest heavily in the creation of suitable UAV operator simulation and training systems.

upcoming conferences

visiongain RSS Feed

  • 8th Monoclonal Antibodies

    Generating annual sales of almost $50bn per year monoclonal antibodies continue to play a vital role in the biopharmaceutical development and represent 42% of the total market. Anticipated steady growth at an annual rate of 6.9% suggests the revenues will reach over $63bn/year by 2015. Primarily driven by the oncology and autoimmune disease treatments, the industry's window will be significantly widened by the introduction of mAbs with novel indications and increasing penetration of the emerging economies.

  • 2nd Annual Biobanking Americas 2012

    Biobanking offers immense opportunities for the entire pharmaceutical market, potentially opening ways to new drug discovery, and personalized medicine. It is not surprising the sector is expanding at such a rate that its total sales are predicted to triple in the next decade and reach $37.62bn by 2022, growing at CAGR of 15.7%. Visiongain's Biobanking Americas 2012 Conference will highlight the latest technological advances in the biobanking sector, most recent progress in the implementation of standard operating procedures, and current social perspective on the biobanking industry.

  • 7th Annual Pharmaceutical Anti-Counterfeiting

    Counterfeit medications are becoming a huge problem for many aspects of the pharmaceutical community from big pharma companies, through to wholesalers and down to end user level where patients are affected. The FDA estimates that 10% of the global market is counterfeit however there is no accurate way to measure this.
2012 Copyright © visiongain. All rights reserved. BSG House, 226-236 City Road, London, EC1V 2QY, United Kingdom Web Design London